Liuxing Feng
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparing neoadjuvant targeted therapy plus transarterial chemoembolization versus triple therapy including immunotherapy in hepatocellular carcinoma: a Chinese multicentre study.
Journal: Cancer immunology, immunotherapy : CII
Published: June 03, 2025
Identification of biomarkers associated with exhausted CD8 + T cells in the tumor microenvironment of intrahepatic cholangiocarcinoma based on Mendelian randomization and bioinformatics analysis.
Journal: Discover oncology
Published: December 19, 2024
Hepatocellular Carcinoma with Multiple Primary Malignancies: A Retrospective Study of 106 Cases.
Journal: Oncology
Published: August 12, 2024
C-FOS inhibition promotes pancreatic cancer cell ferroptosis by transcriptionally regulating the expression of SLC7A11.
Journal: Functional & integrative genomics
Published: June 05, 2024
LINC02875 Upregulation Contributed to Poor Prognosis for the Hepatocellular Carcinoma and Progression for the Cancerous Cells.
Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Published: September 02, 2022
Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma.
Journal: Clinics and research in hepatology and gastroenterology
Published: May 20, 2022
Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 01, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026